Results per Page:
When it comes to low-affinity HER2 CAR T cells, less is more
From the Riddell lab, Translational Science and Therapeutics Division and Cancer Immunology Program
A new study urges CARe when considering multispecific CAR-T cell therapy
From the Riddell Lab, Translational Science and Therapeutics Division
Red Light, Green Light: Precise cell targeting with Co-LOCKR
From the Baker, Riddell, and Pun Labs, Cancer Basic Biology, Cancer Consortium
When life science gives you lemons: T cells as a vaccine platform
From the Riddell Lab, Clinical Research Division
Remodeling the tumor microenvironment for improved CAR T-cell therapy
From the Riddell and Srivastava Labs, Clinical Research Division
Selective stimulation of neoantigen-specific T cells by immunotherapy
From the Riddell Lab, Clinical Research Division
Stronger and faster is not always better
From the Riddell, Paulovich Labs, Clinical Research Division and Gottardo Lab, Vaccine and Infectious Disease Division.